Paul Hagebusch1, Philipp Faul2, Christian Ruckes3, Philipp Störmann4, Ingo Marzi4, Reinhard Hoffmann2, Uwe Schweigkofler2, Yves Gramlich2. 1. Department of Trauma and Orthopedic Surgery, BG Unfallklinik Frankfurt Am Main gGmbH, Friedberger Landstr. 430, 60389, Frankfurt am Main, Germany. Paul.Hagebusch@BGU-Frankfurt.de. 2. Department of Trauma and Orthopedic Surgery, BG Unfallklinik Frankfurt Am Main gGmbH, Friedberger Landstr. 430, 60389, Frankfurt am Main, Germany. 3. Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz, Langenbeckstraße 1, 55131, Mainz, Germany. 4. Department of Trauma, Hand and Reconstructive Surgery, Hospital of the Goethe University Frankfurt Am Main, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Abstract
BACKGROUND: Two-tier trauma team activation (TTA)-protocols often fail to safely identify severely injured patients. A possible amendment to existing triage scores could be the measurement of serum lactate. The aim of this study was to determine the ability of the combination of serum lactate and age to predict severe injuries (ISS > 15). METHODS: We conducted a retrospective cohort study in a single level one trauma center in a 20 months study-period and analyzed every trauma team activation (TTA) due to the mechanism of injury (MOI). Primary endpoint was the correlation between serum lactate (and age) and ISS and mortality. The validity of lactate (LAC) and lactate contingent on age (LAC + AGE) were assessed using the area under the curve (AUC) of the receiver operating characteristics (ROC) curve. We used a logistic regression model to predict the probability of an ISS > 15. RESULTS: During the study period we included 325 patients, 75 met exclusion criteria. Mean age was 43 years (Min.: 11, Max.: 90, SD: 18.7) with a mean ISS of 8.4 (SD: 8.99). LAC showed a sensitivity of 0.82 with a specificity of 0.62 with an optimal cutoff at 1.72 mmol/l to predict an ISS > 15. The AUC of the ROC for LAC was 0.764 (95% CI: 0.67-0.85). The LAC + AGE model provided a significantly improved predictive value compared to LAC (0.765 vs. 0.828, p < 0.001). CONCLUSIONS: The serum lactate concentration is able to predict injury severity. The prognostic value improves significantly taking the patients age into consideration. The combination of serum lactate and age could be a suitable Ad-on to existing two-tier triage protocols to minimize undertriage. LEVEL OF EVIDENCE: Level IV, retrospective cohort study.
BACKGROUND: Two-tier trauma team activation (TTA)-protocols often fail to safely identify severely injured patients. A possible amendment to existing triage scores could be the measurement of serum lactate. The aim of this study was to determine the ability of the combination of serum lactate and age to predict severe injuries (ISS > 15). METHODS: We conducted a retrospective cohort study in a single level one trauma center in a 20 months study-period and analyzed every trauma team activation (TTA) due to the mechanism of injury (MOI). Primary endpoint was the correlation between serum lactate (and age) and ISS and mortality. The validity of lactate (LAC) and lactate contingent on age (LAC + AGE) were assessed using the area under the curve (AUC) of the receiver operating characteristics (ROC) curve. We used a logistic regression model to predict the probability of an ISS > 15. RESULTS: During the study period we included 325 patients, 75 met exclusion criteria. Mean age was 43 years (Min.: 11, Max.: 90, SD: 18.7) with a mean ISS of 8.4 (SD: 8.99). LAC showed a sensitivity of 0.82 with a specificity of 0.62 with an optimal cutoff at 1.72 mmol/l to predict an ISS > 15. The AUC of the ROC for LAC was 0.764 (95% CI: 0.67-0.85). The LAC + AGE model provided a significantly improved predictive value compared to LAC (0.765 vs. 0.828, p < 0.001). CONCLUSIONS: The serum lactate concentration is able to predict injury severity. The prognostic value improves significantly taking the patients age into consideration. The combination of serum lactate and age could be a suitable Ad-on to existing two-tier triage protocols to minimize undertriage. LEVEL OF EVIDENCE: Level IV, retrospective cohort study.
Authors: Ellen J MacKenzie; Sharada Weir; Frederick P Rivara; Gregory J Jurkovich; Avery B Nathens; Weiwei Wang; Daniel O Scharfstein; David S Salkever Journal: J Trauma Date: 2010-07
Authors: Craig D Newgard; Zhuo Yang; Daniel Nishijima; K John McConnell; Stacy A Trent; James F Holmes; Mohamud Daya; N Clay Mann; Renee Y Hsia; Tom D Rea; N Ewen Wang; Kristan Staudenmayer; M Kit Delgado Journal: J Am Coll Surg Date: 2016-03-03 Impact factor: 6.113
Authors: Frank J Voskens; Eveline A J van Rein; Rogier van der Sluijs; Roderick M Houwert; Robert Anton Lichtveld; Egbert J Verleisdonk; Michiel Segers; Ger van Olden; Marcel Dijkgraaf; Luke P H Leenen; Mark van Heijl Journal: JAMA Surg Date: 2018-04-01 Impact factor: 14.766
Authors: Eveline A J van Rein; R Marijn Houwert; Amy C Gunning; Rob A Lichtveld; Luke P H Leenen; Mark van Heijl Journal: J Trauma Acute Care Surg Date: 2017-08 Impact factor: 3.313
Authors: Michael Scott; Waleed Abouelela; David N Blitzer; Timothy Murphy; Gregory Peck; Matthew Lissauer Journal: Value Health Date: 2020-05-04 Impact factor: 5.725